Clinical Trial Update: Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 long-term extension study evaluating the safety of dutogliptin/PHX1149T in Type 2 Diabetes Mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin (dutogliptin)
• PHX1149T (PHX1149T)

Snippet

Sponsor: Phenomix | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED